Sequencing of SARS-CoV-2 - first update
This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on which technologies to use and/or in deciding on the role of sequencing for SARS-CoV-2 diagnostics, research, outbreak investigations and surveillance.
ECDC rapid assessment of laboratory practices and needs related to COVID-19
This report assesses the current status of the EU/EEA and the UK COVID-19 laboratory response based on a short survey sent to all Member States and the UK.
Ninth external quality assessment scheme for typing of Shiga toxin-producing Escherichia coli
This report presents the results of the ninth round of the external quality assessment (EQA-9) scheme for typing of Shiga toxin-producing Escherichia coli (STEC).
Fourth external quality assessment on species identification and antimicrobial susceptibility testing of Campylobacter, 2018
This report presents the results of the fourth round of the EQA on antimicrobial susceptibility testing (AST) for national public health laboratories for Campylobacter (Campylobacter EQA4-AST) within the Food‐ and Waterborne Diseases and Zoonoses Network (FWD-Net). The objectives of this EQA4-AST were to determine the accuracy of quantitative AST results reported by participants; to identify common laboratory problems related to the guidance in the EU protocol, and to assess the overall comparability of routinely collected AST data from national public health reference laboratories across Europe.
External quality assessment (EQA) of performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net), 2019
This report provides an analysis of the external quality assessment (EQA) for the antimicrobial susceptibility testing (AST) performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net) in 2019. A total of 952 laboratories (1–95 per country) from 30 EU/EEA countries participated in the EQA exercise.
EU Laboratory Capability Monitoring System (EULabCap), 2018
This fifth consecutive EULabCap report presents EU/EEA laboratory capabilities and capacities in 2018 and the trends of previous survey results over the period 2013–2018.
Retirement symposium on public health microbiology, celebrating the career of Marc Struelens
Public health microbiology: from managing antimicrobial resistance to COVID-19 - Celebrating the career of Marc Struelens
Third external quality assessment on antimicrobial susceptibility testing and detection of ESBL-, acquired AmpC-, and carbapenemase-production of Salmonella, 2017
This report presents the results of the third round of the external quality assessment (EQA) on antimicrobial
susceptibility testing (AST) for national public health laboratories on Salmonella (hereafter Salmonella EQA3-AST).
An overview of the rapid test situation for COVID-19 diagnosis in the EU/EEA
According to EU recommendations, timely and accurate COVID-19 laboratory testing is an essential part of the management of COVID-19 for slowing down the pandemic, supporting decisions on infection control strategies and patient management at healthcare facilities, and detecting asymptomatic cases that could spread the virus further if not isolated.